Skip to main content

Table 1 Demographic and disease data on CCM sporadic patients and controls

From: CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study

(A) CCM sporadic patients (n = 60)

  

Age of symptoms onset

   

Gender

n

Mean ± SD

Range

 

Lesion number

Male

24

35,6 ± 19,1

10–71

 

2/60 > 1 lesion

Female

36

42,2 ± 18,3

15–73

  

Overall

60

39,5 ± 18,7

10–73

  

Male + Female (asymptomatic)

2 + 2

    

(B) Healthy controls (n = 350)

   

Age

  
 

n

Mean ± SD

Range

 

Male

204

44,3 ± 17,9

12–73

  

Female

146

42,3 ± 18,3

12–73

  

Overall

350

43,5 ± 18,1

12–73

  
  1. p > 0.05 indicates no significant differences. Statistical analysis was tested by the Student’s t-test. CCM, cerebral cavernous malformation; SD, standard deviation
  2. The age of symptoms onset in all patients (with the exception of asymptomatic patients) coincides with the age at diagnosis
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us